IDEXX Laboratories Inc (FRA:IX1)
€ 473.8 -0.90 (-0.19%) Market Cap: 38.07 Bil Enterprise Value: 38.87 Bil PE Ratio: 40.44 PB Ratio: 27.96 GF Score: 96/100

IDEXX Laboratories Inc at Stifel Jaws & Paws Conference Transcript

May 27, 2026 / 02:55PM GMT
Release Date Price: €477.4 (-0.93%)
Jonathan Block
Stifel Nicolaus & Company Inc - Analyst

It's Jon Block with Stifel. Good to see everyone. We're going to push forward. And next up on stage, we have IDEXX Laboratories, the leader in animal health diagnostics and joining me on the stage is the company's relatively new President and CEO, Mike Erickson; as well as John Ravis, Vice President of IR. Guys, thanks very much for joining Jaws & Paws again.

Mike Erickson
IDEXX Laboratories Inc - President, Chief Executive Officer

Thanks for having us, Jon.

Questions & Answers

Jonathan Block
Stifel Nicolaus & Company Inc - Analyst

Mike, I got sort of the typical tee-up question, 30 days on the job, give or take, but you have been at IDEXX for 15 years roughly. So just walk us through maybe those top two or three goals that you see for the company that you're looking to implement going forward?

Mike Erickson
IDEXX Laboratories Inc - President, Chief Executive Officer

Well, first off, huge,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot